Skip to main content
DNA Labs India

Newborn Screening Panel 7 Test

DNA Labs India | ISO 9001:2015 Certified

Newborn Screening Panel 7 Test

Short Name: NBS Panel 7

Also known as: Newborn Metabolic Screening, Neonatal Screening Panel, NBS Panel 7, Newborn Genetic Screening Panel

Newborn Screening Panel 7 Test test available at DNA Labs India for ₹3,000. Uses Fluoroimmunoassay on Heel prick blood on filter paper samples. Results in Reports are typically available the next working day after the sample is received at the laboratory. Sample accepted Monday through Friday by 9 AM.. Free home collection in 300+ cities across India.

ScreeningNewborn (0-28 days)🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the Newborn Screening Panel 7 Test is to identify seven potentially serious genetic and metabolic conditions in newborns before symptoms develop. Early detection enables prompt treatment—such as dietary management for PKU and galactosemia, thyroid hormone replacement for congenital hypothyroidism, biotin supplementation for biotinidase deficiency, hydrocortisone therapy for congenital adrenal hyperplasia, infection prevention for G6PD deficiency, and pulmonary management for cystic fibrosis—thereby preventing irreversible organ damage, intellectual disability, and life-threatening complications. This screening is a cornerstone of preventive paediatric healthcare and is recommended by national and international health bodies including the WHO and ICMR.

Test Code
1308
CPT Code
84030
ICD Code
Z13.0
Price
₹3,000
Sample Type
Heel prick blood on filter paper
Result Time
Reports are typically available the next working day after the sample is received at the laboratory. Sample accepted Monday through Friday by 9 AM.
Fasting Required
No
Method
Fluoroimmunoassay
Step 1

Sample Collection

Clinical details and drug history must accompany the sample. No fasting is required. The test is ideally performed between 48 to 72 hours after birth.

Method: Heel prick

Step 2

Laboratory Analysis

A small blood sample is collected from the newborn's heel (heel prick). One drop of blood is applied to each of 3 spots on a special filter paper card available from LPL.

Step 3

Report Delivery

The filter paper card is allowed to dry at room temperature, then shipped refrigerated or frozen to the laboratory for analysis.

Timeline: Reports are typically available the next working day after the sample is received at the laboratory. Sample accepted Monday through Friday by 9 AM.

Patient Instructions

1
Before the Test:No special preparation is required. The test is ideally performed 48 to 72 hours after birth. Clinical details and any drug history should be provided along with the sample.
2
During the Test:The procedure involves a small heel prick to collect blood drops onto a filter paper card. The entire process takes less than 5 minutes and causes minimal discomfort to the newborn.
3
After the Test:The filter paper is allowed to dry and is sent to the laboratory for analysis. There is no post-procedure care required for the heel prick. A small bandage may be applied.

About This Test

Who Should Get This Test

The purpose of the Newborn Screening Panel 7 Test is to identify seven potentially serious genetic and metabolic conditions in newborns before symptoms develop. Early detection enables prompt treatment—such as dietary management for PKU and galactosemia, thyroid hormone replacement for congenital hypothyroidism, biotin supplementation for biotinidase deficiency, hydrocortisone therapy for congenital adrenal hyperplasia, infection prevention for G6PD deficiency, and pulmonary management for cystic fibrosis—thereby preventing irreversible organ damage, intellectual disability, and life-threatening complications. This screening is a cornerstone of preventive paediatric healthcare and is recommended by national and international health bodies including the WHO and ICMR.

How to Prepare

  • Collect the sample between 48 to 72 hours after birth for optimal accuracy
  • Ensure the heel is properly warmed before the heel prick to facilitate blood flow
  • Apply one full drop of blood to each of the 3 designated spots on the filter paper
  • Allow the filter paper to air dry completely at room temperature before packaging
  • Ship the sample refrigerated or frozen with accompanying clinical details and drug history
  • Ensure the sample reaches the laboratory within the specified stability window

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"As an obstetrician, I routinely advise expectant parents about the importance of newborn screening. The Newborn Screening Panel 7 Test is a simple, cost-effective measure that can identify serious metabolic and genetic conditions before symptoms appear. Early identification allows for immediate intervention—dietary modifications, enzyme replacement, or medication—dramatically improving long-term outcomes. I recommend every parent arrange this screening within the first 48 to 72 hours of birth. Discussing this test during antenatal visits ensures timely planning and helps parents understand the significance of early detection for conditions like congenital hypothyroidism, galactosemia, and congenital adrenal hyperplasia."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeHeel prick blood on filter paper
Sample Volume1 drop of heel prick blood each on 3 spots of filter paper
ContainerFilter paper card available from LPL
Collection MethodHeel prick

Sample Stability

Room Temperature: 2 hours
Refrigerator (2-8°C): 1 week
Frozen (-20°C): 1 week
Sample Rejection Criteria:
  • Filter paper not fully saturated with blood
  • Sample contaminated or clotted on filter paper
  • Sample collected before 48 hours of life without clinical justification
  • Sample received beyond the stability window
  • Missing clinical details or patient identification

Understanding Your Results

The Newborn Screening Panel 7 Test evaluates seven critical analytes associated with genetic and metabolic conditions. A normal result for each parameter indicates a low likelihood of the corresponding disorder. An abnormal result does not confirm a diagnosis but signals the need for confirmatory testing. Results must always be interpreted by a qualified healthcare professional in conjunction with clinical findings and family history.
📊

TSH

📊

17-Hydroxyprogesterone

📊

Phenylalanine

📊

G6PD

📊

Galactosemia (GALT)

📊

Biotinidase

📊

IRT (Cystic Fibrosis)

⚠️ When to Consult a Doctor:

Consult your paediatrician or genetic counsellor immediately if any parameter in the Newborn Screening Panel 7 Test is reported as abnormal. Do not wait for symptoms to appear. Early consultation allows for prompt confirmatory testing and initiation of treatment, which is critical for preventing irreversible complications in conditions such as congenital hypothyroidism, PKU, galactosemia, and congenital adrenal hyperplasia.

Limitations

  • This screening test identifies risk and does not provide a definitive diagnosis; confirmatory testing is required for any positive result
  • The panel does not screen for all genetic or metabolic disorders
  • Rare variants of conditions may not be detected by the screening methods used
  • Results may be affected by pre-analytical factors such as sample handling and transport conditions
  • False negatives can occur, particularly if the sample is collected before 48 hours of life

Risks & Considerations

  • The heel prick is a minimally invasive procedure with negligible risk
  • Mild bruising or temporary discomfort at the puncture site
  • Very rare risk of minor infection at the puncture site

Interfering Factors

  • Premature birth may affect certain reference ranges, particularly 17-OHP and IRT
  • Blood transfusion prior to sample collection may interfere with results
  • Timing of sample collection: screening performed too early (before 48 hours) may yield false results
  • Maternal medications or intravenous feeding may affect certain analyte levels
  • Improper sample collection technique or insufficient blood saturation on filter paper

Compare With Similar Tests

TestNewborn Screening Panel 7 TestExpanded Newborn Screening Panel (Tandem Mass Spectrometry)Basic Newborn Screening (TSH + PKU only)Genetic Carrier Screening (Parents)
ComparisonNewborn Screening Panel 7 Test

Frequently Asked Questions

What is the Newborn Screening Panel 7 Test?
The Newborn Screening Panel 7 Test is a screening test performed on newborns to detect seven critical genetic and metabolic disorders: Congenital Hypothyroidism, G6PD Deficiency, Phenylketonuria (PKU), Cystic Fibrosis, Congenital Adrenal Hyperplasia, Galactosemia, and Biotinidase Deficiency. It involves collecting a small blood sample from the baby's heel.
When should the Newborn Screening Panel 7 Test be performed?
The test should ideally be performed between 48 to 72 hours after birth. This timing ensures that the newborn has been exposed to feeding and that metabolite levels have stabilised, providing the most accurate screening results.
How is the blood sample collected for this test?
The sample is collected through a heel prick procedure. A small lancet is used to make a tiny puncture on the newborn's heel, and blood drops are applied onto a special filter paper card with three designated spots. The procedure is quick and causes minimal discomfort.
What disorders does the Newborn Screening Panel 7 Test detect?
This test screens for seven conditions: Congenital Hypothyroidism (via TSH), G6PD Deficiency, Phenylketonuria/PKU (via Phenylalanine), Cystic Fibrosis (via IRT), Congenital Adrenal Hyperplasia (via 17-Hydroxyprogesterone), Galactosemia (via GALT enzyme), and Biotinidase Deficiency.
What is the cost of the Newborn Screening Panel 7 Test in India?
The cost of the Newborn Screening Panel 7 Test at DNA Labs India is Rs 3000. This price includes free home sample collection and digital report delivery. Prices at other laboratories may vary.
Is the test painful for the newborn?
The heel prick procedure involves a very small puncture and causes only momentary discomfort. Most babies cry briefly and are easily comforted. It is a minimally invasive and safe procedure with negligible risk.
What happens if the screening results are abnormal?
An abnormal screening result does not confirm a diagnosis. Your paediatrician will recommend confirmatory testing, which may include additional blood tests, genetic analysis, or enzyme assays. Early detection and intervention can prevent serious complications in most cases.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for the Newborn Screening Panel 7 Test across major cities in India. You can book online and a trained phlebotomist will collect the sample from your home.
How long does it take to receive the test results?
Results are typically available the next working day after the sample is received at the laboratory. Samples accepted Monday through Friday by 9 AM. Reports are delivered via online portal, email, or WhatsApp.
Does the baby need to fast before the test?
No, fasting is not required. In fact, it is recommended that the newborn has been fed at least once before the sample is collected to ensure accurate metabolite levels for the screening.
Is the Newborn Screening Panel 7 Test mandatory in India?
While newborn screening is recommended by the Indian Council of Medical Research (ICMR) and the Ministry of Health, it is not currently mandated by law across all states in India. However, it is considered a standard of care and strongly recommended by paediatricians and geneticists.
Can this test detect all genetic disorders in newborns?
No, the Newborn Screening Panel 7 Test screens for seven specific genetic and metabolic conditions. It does not cover all genetic or hereditary disorders. For more comprehensive screening, an Expanded Newborn Screening Panel or genetic testing may be recommended by your doctor.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.